Alibaba: Re-Rating Catalysts Finally Kick In

Summary:

  • Chinese monetary stimulus is a strong re-rating catalyst. Dovish surprises and continued rate cuts and measures to encourage stock pledges and buybacks can support BABA stock and other Chinese equities.
  • There are signs of a paradigm shift in market sentiment. Alibaba investor David Tepper is ‘buying everything’ China-related. The last time he said this was in 2010 for US equities.
  • BABA stock valuation is still heavily discounted and attractive and is no longer in a value trap. There is a catalyst for a material re-rating.
  • Relative technicals vs the S&P 500 is bullish, with further room for upside and hence outperformance.
  • A rebound in Chinese retail sales data is something that I expect going forward. I am also watching the US Fed’s policy decisions for clues on Chinese rate decisions.

China"s National People"s Congress - News Conference Of Central Bank

Lintao Zhang/Getty Images News

Performance Assessment

My timing on Alibaba (NYSE:BABA) (OTCPK:BABAF) has been quite good as I have held back on rating it a ‘Buy’ when it was arguably still in a slowly declining


Analyst’s Disclosure: I/we have a beneficial long position in the shares of BABA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *